
Dennis Michael White
Examiner (ID: 16861, Phone: (571)270-3747 , Office: P/1798 )
| Most Active Art Unit | 1798 |
| Art Unit(s) | 1798, 1772, 1797, 1758 |
| Total Applications | 1072 |
| Issued Applications | 664 |
| Pending Applications | 68 |
| Abandoned Applications | 364 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8257652
[patent_doc_number] => 08207132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof'
[patent_app_type] => utility
[patent_app_number] => 11/572719
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 5736
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11572719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/572719 | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof | Jul 27, 2005 | Issued |
Array
(
[id] => 5769160
[patent_doc_number] => 20060019921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Nucleic acid adjuvants'
[patent_app_type] => utility
[patent_app_number] => 11/179798
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 28773
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019921.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179798 | Nucleic acid adjuvants | Jul 12, 2005 | Abandoned |
Array
(
[id] => 4651530
[patent_doc_number] => 20080038786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Method of Producing Substance'
[patent_app_type] => utility
[patent_app_number] => 11/630396
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6400
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630396 | Process for producing L-glutamine using Escherichia coli with deficient glnB and glnE function | Jun 23, 2005 | Issued |
Array
(
[id] => 4853125
[patent_doc_number] => 20080318868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/630115
[patent_app_country] => US
[patent_app_date] => 2005-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14257
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630115 | Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation | Jun 22, 2005 | Issued |
Array
(
[id] => 5397349
[patent_doc_number] => 20090317412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Induction of an immune response against streptococcus pneumoniae polyaccharides'
[patent_app_type] => utility
[patent_app_number] => 11/628265
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15214
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317412.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628265 | Induction of an immune response against streptococcus pneumoniae polyaccharides | Jun 2, 2005 | Abandoned |
Array
(
[id] => 7046131
[patent_doc_number] => 20050250726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 11/127654
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28015
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250726.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127654
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127654 | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases | May 11, 2005 | Abandoned |
Array
(
[id] => 7068997
[patent_doc_number] => 20050244380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/128127
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11217
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128127 | Immunomodulatory oligonucleotides | May 10, 2005 | Abandoned |
Array
(
[id] => 7068997
[patent_doc_number] => 20050244380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/128127
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11217
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128127 | Immunomodulatory oligonucleotides | May 10, 2005 | Abandoned |
Array
(
[id] => 6944359
[patent_doc_number] => 20050196408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Method of administering FimH protein as a vaccine for urinary tract infections'
[patent_app_type] => utility
[patent_app_number] => 11/110609
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24133
[patent_no_of_claims] => 209
[patent_no_of_ind_claims] => 208
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110609 | Method of administering FimH protein as a vaccine for urinary tract infections | Apr 18, 2005 | Abandoned |
Array
(
[id] => 7220247
[patent_doc_number] => 20050260692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/105236
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16982
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105236 | Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine | Apr 12, 2005 | Abandoned |
Array
(
[id] => 5585012
[patent_doc_number] => 20090104214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Synthetic peptides containing the motif \"YWWLXP\" as anthrax toxin antidotes'
[patent_app_type] => utility
[patent_app_number] => 11/547092
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6336
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547092
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547092 | Synthetic peptides containing the motif "YWWLXP" as anthrax toxin antidotes | Mar 24, 2005 | Abandoned |
Array
(
[id] => 5336802
[patent_doc_number] => 20090053266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Apicomplex vaccine strains of a family of sarcocystidae'
[patent_app_type] => utility
[patent_app_number] => 10/585721
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8622
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585721
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585721 | Apicomplex vaccine strains of a family of Sarcocystidae | Jan 12, 2005 | Issued |
Array
(
[id] => 4921529
[patent_doc_number] => 20080069844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Mucosal Vaccine Adjuvants Containing Bacterial Flagellins as an Active Component'
[patent_app_type] => utility
[patent_app_number] => 10/585880
[patent_app_country] => US
[patent_app_date] => 2005-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4966
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585880 | Mucosal vaccine adjuvants containing bacterial flagellins as an active component | Jan 11, 2005 | Issued |
Array
(
[id] => 5799375
[patent_doc_number] => 20060034871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Immunogenic compositions for Chlamydia trachomatis'
[patent_app_type] => utility
[patent_app_number] => 11/018868
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 48227
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034871.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018868
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018868 | Immunogenic compositions for Chlamydia trachomatis | Dec 21, 2004 | Pending |
Array
(
[id] => 7199851
[patent_doc_number] => 20050164931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Protein ACA1 of antrodia camphorata'
[patent_app_type] => utility
[patent_app_number] => 11/015078
[patent_app_country] => US
[patent_app_date] => 2004-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7255
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015078
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015078 | Protein ACA1 of Antrodia camphorata | Dec 17, 2004 | Issued |
Array
(
[id] => 4989309
[patent_doc_number] => 20070155650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/596815
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 3410
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155650.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596815 | Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases | Dec 13, 2004 | Abandoned |
Array
(
[id] => 5842214
[patent_doc_number] => 20060121031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Relay vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/004961
[patent_app_country] => US
[patent_app_date] => 2004-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11126
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121031.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004961
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004961 | Relay vaccine | Dec 6, 2004 | Abandoned |
Array
(
[id] => 4976769
[patent_doc_number] => 20070218000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Protein Nmb1125 and Use Thereof in Pharmaceutical Formulations'
[patent_app_type] => utility
[patent_app_number] => 10/580508
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6857
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580508 | Protein NMB1125 and use thereof in pharmaceutical formulations | Dec 1, 2004 | Issued |
Array
(
[id] => 6957951
[patent_doc_number] => 20050214321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Recombinant icosahedral virus like particle production in pseudomonads'
[patent_app_type] => utility
[patent_app_number] => 11/001626
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28588
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001626 | Recombinant icosahedral virus like particle production in pseudomonads | Nov 30, 2004 | Abandoned |
Array
(
[id] => 6951843
[patent_doc_number] => 20050226937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants'
[patent_app_type] => utility
[patent_app_number] => 11/001563
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10080
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001563 | Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants | Nov 29, 2004 | Abandoned |